| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |